Resmed CDI (ASX:RMD)
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Resmed CDI (ASX:RMD) share price
Resmed CDI (ASX:RMD) share price news
The Match Out: Energy leads the ASX to 12-month lows, IGO face earnings issues
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.79% to 6772.90.
The Match Out: Marginal gains heading into the weekend cant offset a tough week
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.21% to 6826.90.
ResMed (ASX:RMD) share price in focus after FY24 Q1 update
After plenty of volatility for the ResMed Inc (ASX:RMD) share price, the healthcare company has released its FY24 first quarter update.
3 things I wish I knew at 23: Why Ozempic isn’t a threat to ResMed (ASX:RMD)
Here are 3 things I wish I knew about life and business at 23. For investors, this simply means: pessimism can work, from time to time. But over the long run — better on a brighter future is much, much, much better bet.
ResMed and CSL shares are cheap & Tesla’s cyber truck is coming to Australia?
Will Ozempic sink ResMed Inc (ASX:RMD) and CSL Limited (ASX:CSL)? Will Tesla’s Cyber Truck come to Australia? The Australian Investors Podcast explains…
Tech, real estate buoy S&P/ASX200 (ASX:XJO): Bapcor Ltd (ASX:BAP) sinks on slowing sales
The local share market snapped its losing streak, with both the All Ordinaries (INDEXASX: XAO) and S&P/ASX200 (INDEXASX: XJO) gaining 0.4% on a settling of bond yields and the latest Reserve Bank meeting minutes.
The Match Out: S&P/ASX 200 (INDEXASX: XJO) flat ahead of US inflation, CSL knocked again
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.037% to 7091.00.
Are Sonic Healthcare Ltd (ASX:SHL) shares a buy today?
Sonic Healthcare Ltd (ASX: SHL) has traditionally viewed as an ASX share that provides a mixture of dividends and defensive growth for investors. However, SHL shares have been sold off 17% over the last 6 months.
S&P/ASX200 (INDEXASX:XJO) feels the rates heat
The Australia share market retreated to a six-month low on Tuesday, as global markets felt the pressure from surging bond yields – despite, in Australia’s case, the Reserve Bank leaving the official cash rate on hold at 4.1 per cent, for a fifth straight month.